<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39422469</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform.</ArticleTitle><Pagination><StartPage>e0067224</StartPage><MedlinePgn>e0067224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.00672-24</ELocationID><Abstract><AbstractText>The goal of this study is to test a novel device and methodology based on the "Pebble" platform and real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) during SARS-CoV-2 detection using crude samples and extracted RNA. The new method employs an inexpensive lightweight device aimed toward rapid point-of-care testing. An extensive evaluation was performed consisting of 1,693 clinical samples across five independent clinical testing centers. Positive colorimetric results were observed within 20 minutes of testing. At a 20-minute time-to-positive cut-off, the specificity is 98.5% with a diagnostic accuracy of 91.9%, compared to qPCR assays. Our findings indicate that the SARS-CoV-2 qcLAMP diagnostic assay in conjunction with the Pebble device is ideal for point-of-care/near-patient testing.IMPORTANCEHere, we describe our analyses and validation of a novel real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) device, available under the name "Pebble" and associated SARS-CoV-2 diagnostic qcLAMP assay for clinical diagnostic use. The analyses were performed in five independent testing sites across Europe using clinical samples from the associated clinical sites and support the use of "pebble" and associated kit in the diagnostic environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Botha</LastName><ForeName>Johannes C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-7635-7810</Identifier><AffiliationInfo><Affiliation>Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals NHS Trust, Advanced Pathogen Diagnostics Unit, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zafilaza</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soulie</LastName><ForeName>Cathia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1706-6869</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spyer</LastName><ForeName>Moira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balaska</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatziioannidou</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BIOPIX DNA TECHNOLOGY PC, Science and Technology Park of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsiakalou</LastName><ForeName>Vaia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadakis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>BIOPIX DNA TECHNOLOGY PC, Science and Technology Park of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skoura</LastName><ForeName>Lemonia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zafiropoulos</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sourvinos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenberg</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0484-4502</Identifier><AffiliationInfo><Affiliation>Research and Technology Innovation Unit, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcelin</LastName><ForeName>Anne-Geneviève</ForeName><Initials>A-G</Initials><AffiliationInfo><Affiliation>Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gizeli</LastName><ForeName>Electra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nastouli</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1684-2013</Identifier><AffiliationInfo><Affiliation>Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals NHS Trust, Advanced Pathogen Diagnostics Unit, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">colorimetric LAMP</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">near-patient</Keyword><Keyword MajorTopicYN="N">point-of-care</Keyword><Keyword MajorTopicYN="N">respiratory virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39422469</ArticleId><ArticleId IdType="doi">10.1128/spectrum.00672-24</ArticleId></ArticleIdList></PubmedData></PubmedArticle>